Publications
- In silico library screening to find novel anticancer agent with chemosensitizing properties: focus on targeting ataxia telangiectasia and Rad3 related kinase2024 | Faculty of Medicine in Hradec Králové
- 7-Azaindole, 2,7-diazaindole, and 1H-pyrazole as core structures for novel anticancer agents with potential chemosensitizing properties2022 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Clinical Candidates Targeting the ATR-CHK1-WEE1 Axis in Cancer2021 | Publication without faculty affiliation
- Discovery of ATR kinase inhibitor berzosertib (VX-970, M6620): Clinical candidate for cancer therapy2020 | Faculty of Medicine in Hradec Králové
- Novel quinazolin-4-one derivatives as potentiating agents of doxorubicin cytotoxicity2019 | Faculty of Medicine in Hradec Králové
- Purin-6-one and pyrrolo[2,3-d]pyrimidin-4-one derivatives as potentiating agents of doxorubicin cytotoxicity2018 | Faculty of Medicine in Hradec Králové
- Novel caffeine derivatives with antiproliferative activity2016 | Faculty of Medicine in Hradec Králové
- Small Molecules Targeting Ataxia Telangiectasia and Rad3-Related (ATR) Kinase: An Emerging way to Enhance Existing Cancer Therapy2016 | Publication without faculty affiliation
- Phosphatidylinositol 3-Kinase (PI3K) and Phosphatidylinositol 3-Kinase-Related Kinase (PIKK) Inhibitors: Importance of the Morpholine Ring2015 | Publication without faculty affiliation
- The development of ataxia telangiectasia mutated kinase inhibitors2014 | Publication without faculty affiliation
Loading network view...